Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 04 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.50 Insider Own24.22% Shs Outstand26.52M Perf Week44.36%
Market Cap105.28M Forward P/E- EPS next Y-0.16 Insider Trans1.02% Shs Float20.09M Perf Month18.15%
Income-7.85M PEG- EPS next Q-0.06 Inst Own36.32% Short Float2.74% Perf Quarter28.06%
Sales18.53M P/S5.68 EPS this Y83.06% Inst Trans-0.51% Short Ratio0.88 Perf Half Y415.58%
Book/sh0.42 P/B9.55 EPS next Y36.89% ROA-53.78% Short Interest0.55M Perf Year501.52%
Cash/sh0.42 P/C9.47 EPS next 5Y-0.47% ROE-83.36% 52W Range0.37 - 5.58 Perf YTD-20.76%
Dividend Est.- P/FCF- EPS past 5Y55.58% ROI-69.66% 52W High-28.85% Beta1.51
Dividend TTM- Quick Ratio2.52 Sales past 5Y62.40% Gross Margin68.58% 52W Low970.08% ATR (14)0.34
Dividend Ex-Date- Current Ratio2.78 EPS Y/Y TTM71.46% Oper. Margin-43.33% RSI (14)60.94 Volatility12.35% 8.79%
Employees100 Debt/Eq0.06 Sales Y/Y TTM19.18% Profit Margin-42.40% Recom1.00 Target Price5.96
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q85.65% Payout- Rel Volume0.84 Prev Close4.01
Sales Surprise22.18% EPS Surprise33.33% Sales Q/Q28.01% EarningsMar 07 AMC Avg Volume621.17K Price3.97
SMA2019.70% SMA503.42% SMA200103.25% Trades Volume524,750 Change-1.00%
Date Action Analyst Rating Change Price Target Change
Dec-15-23Initiated H.C. Wainwright Buy $6.50
Nov-11-20Upgrade ROTH Capital Neutral → Buy $5 → $7
May-27-20Initiated Dougherty & Company Buy $8.50
Oct-02-17Initiated H.C. Wainwright Buy $12
Mar-01-24 08:00AM
Feb-29-24 04:05PM
Jan-19-24 04:05PM
Jan-17-24 08:05AM
08:50AM Loading…
Dec-20-23 08:50AM
Dec-12-23 07:00AM
Dec-01-23 10:00AM
Nov-20-23 04:16PM
Nov-08-23 11:47AM
Nov-07-23 04:05PM
Nov-06-23 08:30AM
Nov-02-23 10:08AM
Oct-31-23 04:05PM
Aug-29-23 04:05PM
12:38PM Loading…
Aug-28-23 12:38PM
Aug-25-23 07:00AM
Aug-24-23 07:33PM
Aug-21-23 04:05PM
Aug-09-23 05:30PM
Aug-02-23 04:05PM
Jul-05-23 10:50AM
Jul-03-23 08:30AM
Jun-14-23 04:05PM
May-22-23 09:55AM
May-10-23 06:05PM
May-09-23 07:05PM
07:45AM Loading…
May-05-23 07:45AM
May-03-23 04:05PM
Apr-10-23 08:30AM
Mar-16-23 05:30AM
Mar-15-23 08:30AM
Mar-14-23 11:11AM
Mar-13-23 09:45AM
Mar-07-23 10:12AM
Mar-06-23 04:05PM
Feb-06-23 04:05PM
Feb-01-23 04:25PM
Jan-30-23 04:05PM
Jan-17-23 04:05PM
Jan-12-23 08:30AM
Jan-10-23 04:17PM
Dec-07-22 05:00PM
Dec-05-22 08:30AM
Nov-21-22 03:04PM
Nov-10-22 05:55PM
Nov-09-22 05:25PM
Nov-03-22 04:05PM
Oct-05-22 04:30PM
Sep-07-22 08:30AM
Aug-30-22 08:30AM
Aug-03-22 06:35PM
Jul-28-22 10:03AM
Jul-27-22 04:15PM
Jul-18-22 12:00PM
Jul-07-22 04:05PM
Jun-14-22 02:45PM
Jun-09-22 04:05PM
May-25-22 10:34AM
May-11-22 06:05PM
May-04-22 04:15PM
Apr-04-22 04:15PM
Mar-09-22 05:35PM
Mar-02-22 04:15PM
Feb-17-22 04:15PM
Feb-14-22 08:30AM
Jan-18-22 07:30AM
Jan-13-22 04:30PM
Jan-10-22 08:30AM
Jan-06-22 04:05PM
Jan-05-22 04:05PM
Nov-10-21 06:25PM
Nov-03-21 04:05PM
Nov-02-21 03:02PM
Oct-15-21 09:15AM
Oct-04-21 04:30PM
Sep-28-21 04:30PM
Sep-07-21 04:30PM
Sep-02-21 04:30PM
Aug-09-21 06:15PM
Aug-02-21 04:05PM
Jul-27-21 08:30AM
Jul-23-21 04:05PM
Jun-28-21 08:30AM
Jun-22-21 04:45PM
Jun-16-21 04:05PM
Jun-15-21 05:15PM
Myomo, Inc. is a medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. It offers MyoPro, an upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KIRK THOMAS FDirectorNov 20Buy3.1050,000155,000136,499Dec 14 07:46 PM
Morris Milton MayoDirectorSep 08Buy1.0615,00015,86777,933Sep 11 05:05 PM
GUDONIS PAUL RChief Executive OfficerAug 30Buy0.7448,40036,039878,245Aug 31 06:26 PM
GUDONIS PAUL RChief Executive OfficerAug 29Buy0.7837,00028,797829,845Aug 30 04:22 PM
HENRY DAVID AChief Financial OfficerAug 29Buy0.6041,66625,000352,193Aug 30 04:36 PM
Kovelman HarryChief Medical OfficerAug 29Buy0.608,3335,000149,556Aug 30 05:00 PM
GUDONIS PAUL RChief Executive OfficerAug 28Buy0.7542,50031,794792,845Aug 30 04:22 PM